10 studies found for:    Polyethylenimine
Show Display Options
Rank Status Study
1 Unknown  Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles
Condition: Carcinoma of Head and Neck
Intervention: Device: polyethylenimine (PEI) nanoparticles.
2 Completed Clinical Study of Antibacterial Nanoparticles Incorporated in Composite Restorations
Condition: Oral Health
Intervention: Device: alkylated polyethylenimine nanoparticles antibacterial evaluation
3 Recruiting The Effects of a Polyethyleneimine-coated Membrane (oXiris™) for Hemofiltration Versus Polymyxin B- Immobilized Fibre Column (Toraymyxin™) for Hemoperfusion on Endotoxin Activity and Inflammatory Conditions in Septic Shock- A Randomized Controlled Pilot Study (ENDoX-study)
Condition: Patients in Septic Shock
Interventions: Device: oXiris™ filter;   Device: Toraymyxin Filter;   Device: Standard of Care
4 Unknown  A Clinical Study: the Antibacterial Effect of Insoluble Antibacterial Nanoparticles (IABN) Incorporated in Dental Materials for Root Canal Treatment
Conditions: Endodontic Treatment;   Irreversible Pulpitis;   Health Pulp;   Infected Pulp
Intervention: Device: IABN
5 Completed Gene Therapy of Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Intervention: Genetic: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes
6 Recruiting Impact of CVVHD With Increased Adsorption Membranes in Septic Acute Kidney Injury
Conditions: Severe Sepsis;   Septic Shock;   Acute Kidney Injury
Interventions: Other: CVVHD;   Other: CVVH
7 Unknown  Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)
Condition: Acute Kidney Injury
Interventions: Drug: heparinized saline priming group;   Drug: nafamostat infusion after heparinized saline priming
8 Completed Clinical Trial to Evaluate the Use of an Adsorption Membrane (OXIRIS®) During Cardiopulmonary Bypass Surgery
Conditions: Cardiac Surgical Procedures;   Cardiopulmonary Bypass
Intervention: Device: OXIRIS®
9 Not yet recruiting Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Gene Therapy product CYL-02;   Drug: Gemcitabine
10 Not yet recruiting Increased Adsorption Membranes During Cardiopulmonary Bypass
Conditions: Cardiopulmonary Bypass;   Acute Kidney Injury;   Systemic Inflammatory Response Sydrome
Intervention: Device: OXIRIS®

Indicates status has not been verified in more than two years